BiBB Receives European CE Mark Approval According to MDR for the Entire EndoDrill Product Family
The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), which has developed the world's first electric-driven endoscopic biopsy instrument, announces that the Company has received CE certification for EndoDrill[®] in accordance with MDR. The market approval allows EndoDrill[®] to be introduced in Europe for all three market segments, i.e. for sampling of the gastrointestinal tract, lungs, and bladder. With the CE mark in place, the Company plans to launch EndoDrill® GI in 2024 to targeted customers. Several clinical market studies are also planned to highlight the